Koivisto P - Search Results

1

Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays.

Mousses S, Bubendorf L, Wagner U, Hostetter G, Kononen J, Cornelison R, Goldberger N, Elkahloun AG, Willi N, Koivisto P, Ferhle W, Raffeld M, Sauter G, Kallioniemi OP. Mousses S, et al. Among authors: koivisto p. Cancer Res. 2002 Mar 1;62(5):1256-60. Cancer Res. 2002. PMID: 11888886

2

Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.

Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, Trapman J, Cleutjens K, Noordzij A, Visakorpi T, Kallioniemi OP. Koivisto P, et al. Cancer Res. 1997 Jan 15;57(2):314-9. Cancer Res. 1997. PMID: 9000575

3

Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.

Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch MJ, Sauter G, Kallioniemi OP. Bubendorf L, et al. Among authors: koivisto p. Cancer Res. 1999 Feb 15;59(4):803-6. Cancer Res. 1999. PMID: 10029066

4

Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

Bubendorf L, Kolmer M, Kononen J, Koivisto P, Mousses S, Chen Y, Mahlamäki E, Schraml P, Moch H, Willi N, Elkahloun AG, Pretlow TG, Gasser TC, Mihatsch MJ, Sauter G, Kallioniemi OP. Bubendorf L, et al. Among authors: koivisto p. J Natl Cancer Inst. 1999 Oct 20;91(20):1758-64. doi: 10.1093/jnci/91.20.1758. J Natl Cancer Inst. 1999. PMID: 10528027

5

Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.

Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, Kallioniemi OP, Gelmann EP. Bowen C, et al. Among authors: koivisto p. Cancer Res. 2000 Nov 1;60(21):6111-5. Cancer Res. 2000. PMID: 11085535

6

Androgen receptor gene alterations and chromosomal gains and losses in prostate carcinomas appearing during finasteride treatment for benign prostatic hyperplasia.

Koivisto PA, Schleutker J, Helin H, Ehren-van Eekelen C, Kallioniemi OP, Trapman J. Koivisto PA, et al. Clin Cancer Res. 1999 Nov;5(11):3578-82. Clin Cancer Res. 1999. PMID: 10589774

7

Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene.

Mononen N, Syrjäkoski K, Matikainen M, Tammela TL, Schleutker J, Kallioniemi OP, Trapman J, Koivisto PA. Mononen N, et al. Among authors: koivisto pa. Cancer Res. 2000 Nov 15;60(22):6479-81. Cancer Res. 2000. PMID: 11103816

8

Androgen receptor gene amplification: a novel molecular mechanism for endocrine therapy resistance in human prostate cancer.

Koivisto P, Visakorpi T, Kallioniemi OP. Koivisto P, et al. Scand J Clin Lab Invest Suppl. 1996;226:57-63. Scand J Clin Lab Invest Suppl. 1996. PMID: 8981668 Review.

9

Androgen receptor gene and hormonal therapy failure of prostate cancer.

Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP. Koivisto P, et al. Am J Pathol. 1998 Jan;152(1):1-9. Am J Pathol. 1998. PMID: 9422516 Free PMC article. Review.

10

ANX7, a candidate tumor suppressor gene for prostate cancer.

Srivastava M, Bubendorf L, Srikantan V, Fossom L, Nolan L, Glasman M, Leighton X, Fehrle W, Pittaluga S, Raffeld M, Koivisto P, Willi N, Gasser TC, Kononen J, Sauter G, Kallioniemi OP, Srivastava S, Pollard HB. Srivastava M, et al. Among authors: koivisto p. Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4575-80. doi: 10.1073/pnas.071055798. Epub 2001 Apr 3. Proc Natl Acad Sci U S A. 2001. PMID: 11287641 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters